• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Studies on Competition and Antitrust Issues in the Pharmaceutical Industry

Studies on Competition and Antitrust Issues in the Pharmaceutical Industry

Paperback

Series: Bestmasters

Business GeneralEconomicsGeneral Political Science

ISBN10: 3658165502
ISBN13: 9783658165505
Publisher: Springer Gabler
Published: Nov 22 2016
Pages: 85
Weight: 0.28
Height: 0.21 Width: 5.83 Depth: 8.27
Language: English
This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug's patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies.

Also in

Business General